Morgan Stanley’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.1M Sell
470,421
-227,302
-33% -$8.07M ﹤0.01% 3210
2025
Q4
$25.1M Buy
697,723
+145,962
+26% +$5.36M ﹤0.01% 2717
2025
Q3
$17.4M Buy
551,761
+83,749
+18% +$3.01M ﹤0.01% 3012
2025
Q2
$19.9M Sell
468,012
-99,043
-17% -$4.12M ﹤0.01% 2811
2025
Q1
$25.3M Buy
567,055
+36,919
+7% +$1.99M ﹤0.01% 2450
2024
Q4
$29.1M Buy
530,136
+25,736
+5% +$1.3M ﹤0.01% 2377
2024
Q3
$21.3M Buy
504,400
+49,034
+11% +$2.33M ﹤0.01% 2737
2024
Q2
$20.9M Sell
455,366
-2,894
-0.6% -$136K ﹤0.01% 2621
2024
Q1
$23.8M Sell
458,260
-2,137,432
-82% -$93.7M ﹤0.01% 2508
2023
Q4
$92.4M Buy
2,595,692
+1,239,266
+91% +$43.2M ﹤0.01% 1809
2023
Q3
$45.5M Buy
1,356,426
+692,260
+104% +$24M ﹤0.01% 1670
2023
Q2
$25M Buy
664,166
+97,985
+17% +$3.22M ﹤0.01% 2246
2023
Q1
$16.6M Sell
566,181
-460,779
-45% -$13.4M ﹤0.01% 2627
2022
Q4
$27.1M Sell
1,026,960
-461,279
-31% -$11M ﹤0.01% 2037
2022
Q3
$34.5M Sell
1,488,239
-185,444
-11% -$5.06M ﹤0.01% 1623
2022
Q2
$42.1M Buy
1,673,683
+1,018,393
+155% +$30.1M 0.01% 1514
2022
Q1
$25M Buy
655,290
+371,447
+131% +$13.4M ﹤0.01% 1879
2021
Q4
$11.2M Sell
283,843
-1,194
-0.4% -$52.3K ﹤0.01% 2834
2021
Q3
$13.9M Sell
285,037
-12,699
-4% -$657K ﹤0.01% 2514
2021
Q2
$15.6M Sell
297,736
-11,914
-4% -$679K ﹤0.01% 2444
2021
Q1
$17.2M Buy
309,650
+94,687
+44% +$4.28M ﹤0.01% 2074
2020
Q4
$6.64M Buy
214,963
+184,732
+611% +$4.4M ﹤0.01% 2953
2020
Q3
$561K Sell
30,231
-106,309
-78% -$1.76M ﹤0.01% 4577
2020
Q2
$1.89M Buy
136,540
+92,821
+212% +$1.26M ﹤0.01% 3654
2020
Q1
$401K Sell
43,719
-641,290
-94% -$9.61M ﹤0.01% 4508
2019
Q4
$11.9M Buy
685,009
+633,748
+1,236% +$10.8M ﹤0.01% 2219
2019
Q3
$777K Buy
51,261
+3,911
+8% +$68.4K ﹤0.01% 4436
2019
Q2
$894K Sell
47,350
-14,505
-23% -$247K ﹤0.01% 4277
2019
Q1
$1.08M Sell
61,855
-285,559
-82% -$5.22M ﹤0.01% 4056
2018
Q4
$6.04M Buy
347,414
+245,180
+240% +$3.67M ﹤0.01% 2675
2018
Q3
$1.45M Buy
102,234
+16,724
+20% +$196K ﹤0.01% 4246
2018
Q2
$829K Sell
85,510
-88,758
-51% -$1.11M ﹤0.01% 4745
2018
Q1
$1.73M Buy
174,268
+172,003
+7,594% +$1.42M ﹤0.01% 4131
2017
Q4
$12K Sell
2,265
-6,740
-75% -$31.1K ﹤0.01% 6188
2017
Q3
$54K Buy
9,005
+7,358
+447% +$28.2K ﹤0.01% 5761
2017
Q2
$5K Sell
1,647
-9,748
-86% -$26.7K ﹤0.01% 6353
2017
Q1
$32K Sell
11,395
-6,875
-38% -$19.4K ﹤0.01% 5960
2016
Q4
$55K Buy
18,270
+18,257
+140,438% +$46.9K ﹤0.01% 5721
2016
Q3
$0 Hold
13
﹤0.01% 6570
2016
Q2
$0 Sell
13
-569
-98% -$1.64K ﹤0.01% 6663
2016
Q1
$3K Buy
582
+504
+646% +$1.41K ﹤0.01% 6364
2015
Q4
$0 Sell
78
-4,202
-98% -$9.39K ﹤0.01% 6799
2015
Q3
$11K Sell
4,280
-23,658
-85% -$77.7K ﹤0.01% 6214
2015
Q2
$100K Sell
27,938
-24,958
-47% -$85.5K ﹤0.01% 5587
2015
Q1
$195K Buy
52,896
+52,858
+139,100% +$180K ﹤0.01% 5220
2014
Q4
$0 Sell
38
-910
-96% -$2.59K ﹤0.01% 6675
2014
Q3
$3K Buy
948
+610
+180% +$2.02K ﹤0.01% 6404
2014
Q2
$1K Sell
338
-1,150
-77% -$4.76K ﹤0.01% 6444
2014
Q1
$7K Buy
1,488
+1,363
+1,090% +$5.14K ﹤0.01% 6192
2013
Q4
$0 Buy
+125
New +$489 ﹤0.01% 6374

Other funds holding VCEL

Morgan Stanley's VCEL Position: Q1 2026 in Review

Morgan Stanley reduced its Vericel Corp (VCEL) stake by 33% in Q1 2026, selling an estimated $8.07M and leaving 470,421 shares worth $15.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3210.

Morgan Stanley first reported a position in VCEL in Q4 2013 and has held it in 50 quarters since. The position peaked at $92.4M in Q4 2023. 279 funds tracked by Wall St. Rank hold VCEL as of Q1 2026.

  • Morgan Stanley held 470,421 shares of Vericel Corp worth $15.1M as of Q1 2026.
  • Morgan Stanley sold 227,302 Vericel Corp shares in Q1 2026, an estimated $8.07M.
  • Vericel Corp made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #3210 holding.
  • Morgan Stanley first reported a position in Vericel Corp in Q4 2013 and has held it in 50 quarters since.
  • Morgan Stanley's Vericel Corp position peaked at $92.4M in Q4 2023.
  • 279 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.